Janssen Submits Marketing Authorisation Application to the European Medicines Agency Seeking Approval of Talquetamab for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma
January 3, 2023Business Services
BEERSE, BELGIUM, 3 January 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the submission of a …
Cost of over 350 drugs expected to increase in 2023
January 3, 2023Sales and Marketing
With many pharma companies preparing for President Joe Biden’s Inflation Reduction Act (IRA) to begin having an impact, and inflation …
Rare cancer drug for young patients approved
January 3, 2023Research and Development
A new treatment option for adult and paediatric patients with a rare soft tissue cancer has been approved. The FDA …
MediWound receives FDA approval for NexoBrid
January 3, 2023Medical Communications
Israeli biopharma company MediWound has secured FDA approval for its wound care product NexoBrid (anacaulase-bcdb). US-based biopharma company Vericel will …
Datar blood test receives FDA Breakthrough Designation
January 3, 2023Medical Communications
Datar Cancer Genetics has secured FDA Breakthrough Designation for their blood test used to detect inaccessible brain tumours, where traditional …
BioNTech begins phase 1 trial for malaria vaccine
December 23, 2022Medical Communications
BioNTech has announced the start of its new first-in-human phase 1 trial for BNT165b1, a candidate from its programme which …
Celltrion submits application for CT-P13 SC to FDA
December 23, 2022Medical Communications
Celltrion has announced that it has finalised its submission of a biologics license application for the subcutaneous version of a …
Moderna signs ten-year deal with UK Government for vaccine production
December 23, 2022Manufacturing and Production
US biotech company Moderna has finalised a partnership with the UK government to produce vaccines, the main element of which …
COVID-19 antiviral treatment shown to speed up recovery in trial
December 23, 2022Medical Communications
Molnupiravir, made by Merck, Sharp and Dohme (MSD), has been found to reduce the recovery time of COVID-19 patients, however …
Treatment for rare, paediatric growth hormone deficiency recommended by NICE for use on the NHS
December 22, 2022Medical Communications
Walton Oaks, 22 December 2022 – Pfizer Ltd today announces that the National Institute for Health and Care Excellence (NICE) …
AstraZeneca shares two new drug approvals in the EU
December 22, 2022Medical Communications
On Wednesday, AstraZeneca announced two drug approvals in the European Union (EU). The first being Imfinzi’s approval for the treatment …
Everest Medicines and licensing partner Pfizer receive FDA and EMA approval for ulcerative colitis drug
December 22, 2022Medical Communications
Everest Medicines, a biopharmaceutical company, has announced that its licensing partner, Pfizer, has received acceptance from the FDA for a …
New monoclonal antibody for hospitalised COVID-19 patients approved by FDA
December 22, 2022Medical Communications
The FDA has approved Roche’s monoclonal antibody which treats hospitalised adult patients with COVID-19. The antibody, Actemra, is already approved …
Abiomed receives FDA approval for heart pump clinical trial
December 22, 2022Research and Development
Abiomed, a leading provider of medical technology focusing on the circulatory system and oxygenation, has announced that the FDA has …
OSE Immunotherapeutics Announces First Patient Dosed with Anti-PD1 Monoclonal Antibody OSE-279 in a Phase 1/2 Clinical Trial in Advanced Solid Tumors or Lymphomas
December 22, 2022Business Services
Nantes, France – December 22,
Innovative Antibody Discovered by RQ Bio Enters Clinic as Part of Antibody Combination Within 12 Months of Discovery
December 21, 2022Medical Communications
LONDON, UK, 21st December 2022 — RQ Bio announces that the first of its discovered monoclonal antibodies to prevent COVID-19 …
Kite set to acquire Tmunity Therapeutics
December 21, 2022Medical Communications
Santa Monica, US-based Kite is set to acquire Philadelphia, US-based Tmunity Therapeutics: a clinical stage, private biotech company. The financial …
Two biotech CEOs charged with defrauding investors over investigational HIV drug
December 21, 2022Medical Communications
Two US biotech CEOs have been highlighted for their roles in a conspiracy to defraud investors in CytoDyn, a company …
Gambia panel recommends Maiden Pharmaceuticals be held culpable for cough syrup deaths
December 21, 2022Medical Communications
A parliamentary committee in The Gambia has recommended prosecution of the Indian pharma manufacturer Maiden Pharmaceuticals, as they have sold …
Tamiflu manufacturers report shortages during high point of flu season
December 21, 2022Medical Communications
The CDC has reported at least 23,000 hospitalisations due to influenza while this year’s flu season is at a high …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
